GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procyon Corp (OTCPK:PCYN) » Definitions » Net Income

PCYN (Procyon) Net Income : $-0.34 Mil (TTM As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Procyon Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Procyon's Net Income for the three months ended in Jun. 2024 was $0.04 Mil. Its Net Income for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.34 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Procyon's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was $0.01.


Procyon Net Income Historical Data

The historical data trend for Procyon's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procyon Net Income Chart

Procyon Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Net Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.69 -0.21 -0.05 -0.34

Procyon Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 -0.03 -0.24 -0.10 0.04

Procyon Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Procyon's Net Income for the fiscal year that ended in Jun. 2024 is calculated as

Net Income(A: Jun. 2024 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-0.171+-0.17+0+0
=-0.34

Procyon's Net Income for the quarter that ended in Jun. 2024 is calculated as

Net Income(Q: Jun. 2024 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=0.025+0.013+0+0
=0.04

Net Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Procyon  (OTCPK:PCYN) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Procyon's Earnings per Share (Diluted) (EPS) for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Procyon Net Income Related Terms

Thank you for viewing the detailed overview of Procyon's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Procyon Business Description

Traded in Other Exchanges
N/A
Address
164 Douglas Road, Oldsmar, FL, USA, 34677
Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.
Executives
Foundation Speer 10 percent owner 2535 SUCCESS DRIVE, ODESSA FL 33556
Suggs Fred Wilson Jr director 60 FOREST LANE, GREENVILLE SC 29605
Steven Mccomas director 800 LASTAHOUSE DRIVE, VIDALIA GA 30474
Monica Mccullough director 1095 55TH TERR SO, SAINT PETERSBURG FL 33705
Joseph Raymond Treshler director PO BOX 5719, CLEARWATER FL 33758
George Otis Borak officer: Vice President 3300 COVE CAY DR, UNIT 7D, CLEARWATER FL 33760
Lynnda L Speer 10 percent owner 2535 SUCCESS DRIVE, ODESSA FL 33556
Richard M. Speer 10 percent owner 104 WOODMONT BOULEVARD, SUITE 415, NASHVILLE TN 37205
Speer Roy M Foundation 10 percent owner 2535 SUCCESS DRIVE, ODESSA FL 33556
Paul Edward Kudelko director 28 WINSTON DR, BELLEAIR FL 33756
Justice Wolfe Anderson director, officer: VP-Sales and Marketing 1300 S HIGHLAND AVE, CLEARWATER FL 33756
Regina Wolfe Anderson director 1300 S HIGHLAND AVE, CLEARWATER FL 33756
Jeffrey S Slowgrove director C/O INFORMATION MANAGEMENT RESOURCES INC, 26750 US HIGHWAY N #500, CLEARWATER FL 34621
John C Anderson Trust 10 percent owner 440 S GULFVIEW BLVD, APT 1702N, CLEARWATER FL 33767
Michael Timothy Foley director 2284 KINGS POINT DRIVE, LARGO FL 33774

Procyon Headlines

No Headlines